MWMinghui Wang

Minghui Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Minghui Wang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Cheng Ran

    Department of Otolaryngology Affiliate Hospital of Hebei University Baoding China

    1 shared publication
  • Dongcheng Wang

    Biomedical Barriers Research Center, Institute of Biomedical Engineering Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin China

    1 shared publication
  • Jia Hao

    Department of Otolaryngology Affiliate Hospital of Hebei University Baoding China

    1 shared publication
  • Xiaobo Ma

    Key Laboratory of Otolaryngology Head and Neck Surgery, Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Ministry of Education Capital Medical University Beijing China

    1 shared publication
  • Xin Zhang

    Biomedical Barriers Research Center, Institute of Biomedical Engineering Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin China

    1 shared publication
  • Zhen Wang

    Biomedical Barriers Research Center, Institute of Biomedical Engineering Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin China

    1 shared publication

Latest Publications

  • Open Access

    Intratympanic dexamethasone microcrystals/lidocaine‐loaded PLGA non‐spherical microparticles for local drug delivery to the inner ear

    by Dongcheng Wang, Xin Zhang, Zhen Wang, Cheng Ran, Jia Hao, Xiaobo Ma, Minghui Wang, Zhimin Zhou

    Background: Sudden sensorineural hearing loss (SSNHL), often associated with tinnitus, significantly impacts individuals' quality of life. Current treatments, such as free drugs via intravenous or intratympanic (IT) administration of dexamethasone (DEX) and lidocaine, face limitations like low bioavailability and rapid drug clearance. To address these challenges, we developed a local co‐delivery system combining DEX microcrystals (DEX MCs) and lidocaine‐loaded poly(lactic‐co‐glycolic acid) (PLGA) non‐spherical microparticles (LPNMs) for sustained drug release in the inner ear. Methods: DEX MCs and LPNMs were prepared using the traditional precipitation technique and double emulsion‐solvent evaporation, respectively. After characterizing physicochemical properties and drug release kinetics, they were dispersed in sodium hyaluronate solution for IT injection, then in vivo pharmacokinetics and biocompatibility in guinea pigs were studied. Results: DEX MCs exhibited stable dissolution, while LPNMs provided sustained lidocaine release, reducing potential side effects. In vivo studies in guinea pigs demonstrated prolonged drug retention in the perilymph and improved pharmacokinetics. Histological evaluation confirmed the good biocompatibility of this combined delivery system, with no significant inner ear damage observed. Conclusion: This co‐delivery system can be used as a depot for delivering both DEX and lidocaine to the inner ear and offers a promising approach for the synergistic treatment of SSNHL associated with tinnitus.